Official SEC submissions

AgomAb Therapeutics SEC Filings

Direct answer

AgomAb Therapeutics's latest SEC filing is 6-K.

It was filed on August 10, 2026, and 8 recent filings are available.

Each row links directly to the SEC document and filing index.

Official SEC EDGAR submissions

Get free AgomAb Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

6-K

Current report

Filed: 2026-08-10

Report date: 2026-08-10

FORM 6-K

Open SEC document View filing index

6-K

Current report

Filed: 2026-08-06

Report date: 2026-08-06

6-K

Open SEC document View filing index

6-K

Current report

Filed: 2026-06-23

Report date: 2026-06-23

FORM 6-K

Open SEC document View filing index

6-K

Current report

Filed: 2026-05-27

Report date: 2026-05-27

FORM 6-K

Open SEC document View filing index

6-K

Current report

Filed: 2026-04-24

Report date: 2026-04-24

FORM 6-K

Open SEC document View filing index

20-F

Periodic report

Filed: 2026-04-23

Report date: 2025-12-31

FORM 20-F

Open SEC document View filing index

6-K

Current report

Filed: 2026-03-05

Report date: 2026-03-05

FORM 6-K

Open SEC document View filing index

6-K

Current report

Filed: 2026-02-09

Report date: 2026-02-09

FORM 6-K

Open SEC document View filing index

Verified data

Recent filing categories: 2
Recent filings: 8
SEC CIK: 0002020932
Latest filing date: August 10, 2026

Explore related company data

View the AgomAb Therapeutics company profile View AgomAb Therapeutics annual financials